Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Planta Med ; 83(3-04): 239-244, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27442262

RESUMO

The trypanocidal potential of the natural chalcone flavokawin B, which was isolated from the hexanic extract of Polygonum ferrugineum Wedd., is reported here. Although flavokawin B is widespread, this is the first report about its trypanocidal properties on both Trypanosoma cruzi (IC50 = 9.5 µM, IC50 = 34.7 µM benznidazol, Y strain) epimastigotes and Trypanosoma brucei (IC50 = 4.8 µM, IC50 = 6.4 µM pentamidine, 29-13 strain) procyclic forms, which was also corroborated on T. brucei strain 427 (IC50 = 6.2 µM). In order to learn more about its properties, unspecific cytotoxicity on Hep G2 cells was investigated as well as the trans-splicing inhibitory potential on T. brucei cells. The results shown here point to flavokawin B as a candidate in the search for new agents. It is also cheaper and less toxic than the available drugs to treat trypanosomiasis with a special focus on sleeping sickness disease.


Assuntos
Flavonoides/farmacologia , Tripanossomicidas/farmacologia , Trypanosoma brucei brucei/efeitos dos fármacos , Trypanosoma cruzi/efeitos dos fármacos , Tripanossomíase/tratamento farmacológico , Sobrevivência Celular/efeitos dos fármacos , Chalcona/farmacologia , Relação Dose-Resposta a Droga , Flavonoides/química , Flavonoides/isolamento & purificação , Células Hep G2 , Humanos , Concentração Inibidora 50 , Polygonum/química , Tripanossomicidas/química , Tripanossomicidas/isolamento & purificação , Trypanosoma brucei brucei/genética , Tripanossomíase Africana/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa